AFP and neoplasm: A diagnosis of HCC was established non-invasively based on multiphasic contrast-enhanced CT demonstrating arterial-phase hyperenhancement with portal/delayed-phase washout, together with elevated tumor markers (AFP 45.9 ng/mL; PIVKA-II 121 mAU/mL) (Figure 3A, 3B).